MSD Europe (Belgium)

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1177/26320843231190026 Dealing with censoring in a network meta-analysis of time-to-event data
https://doi.org/10.21203/rs.3.rs-4181221/v1 A Global Industry Survey on Post-Approval Change Management and Use of Reliance
https://doi.org/10.1016/j.jval.2024.03.647 EE349 Cost-Effectiveness of First-Line Treatment With Pembrolizumab for Unresectable or Metastatic MSI-H/dMMR Colorectal Cancer (CRC) in the United States Based on 5-Year Follow-up Data
https://doi.org/10.1016/j.jval.2024.03.187 CO99 Validation of Overall Survival (OS) Extrapolations Using 5-Year Follow-up Data From the Keynote-177 MSI-H/dMMR Metastatic Colorectal Cancer (mCRC) Study
https://doi.org/10.1007/s10637-024-01462-y A randomized phase 1 study of safety, tolerability, and pharmacokinetics of MK-1088, a novel dual adenosine receptor antagonist, in healthy adult participants
https://doi.org/10.1183/13993003.congress-2024.pa5173 Good health’ for patients with PPF: Insights from patient-led international focus groups
https://doi.org/10.1183/13993003.congress-2024.pa2444 Identifying outcome domains to establish a core outcome set for progressive pulmonary fibrosis: a scoping review.
https://doi.org/10.1183/13993003.congress-2024.oa2865 Health outcomes in IPF and PPF: European survey on healthcare professionals’ views and practices
https://doi.org/10.1007/s43441-024-00733-3 Correction: A Global Industry Survey on Post-Approval Change Management and Use of Reliance
https://doi.org/10.1200/jco.2025.43.16_suppl.3631 Quality-adjusted time without symptoms of disease or toxicity (Q-TWiST) analysis of pembrolizumab (pembro) versus chemotherapy (chemo) in microsatellite instability–high (MSI-H)/mismatch repair–deficient (dMMR) metastatic colorectal cancer (mCRC) in the KEYNOTE-177 trial.
https://doi.org/10.12688/f1000research.146108.2 Are Narrative CVs contributing towards shifting research culture? Workshop Report from the 2023 Recognition and Rewards Festival
https://doi.org/10.1183/13993003.congress-2025.pa5870 Healthy Lungs for Life for Schools – evaluating the role of lung health tests in the classroom
https://doi.org/10.1183/13993003.congress-2025.pa6021 EU PAL-COPD: Integrating palliative care in treatment for advanced COPD across Europe
https://doi.org/10.1007/s11136-025-04109-4 Analysis of quality-adjusted survival time without symptoms or toxicity for pembrolizumab plus chemotherapy as treatment for previously untreated participants with advanced or metastatic esophageal cancer
https://doi.org/10.1080/13696998.2026.2639229 Cost-effectiveness of pembrolizumab plus chemotherapy vs cemiplimab plus chemotherapy for first-line metastatic non–small cell lung cancer: a US payer perspective using a matching-adjusted indirect comparison
https://doi.org/10.5281/zenodo.19261068 The Universal Proportional Coordinate System: A Unified Architecture for Pythagorean Tuning, Exact-Ratio Data Encoding, and Domain-Independent Geometric Data Distribution
https://doi.org/10.5281/zenodo.19261067 The Universal Proportional Coordinate System: A Unified Architecture for Pythagorean Tuning, Exact-Ratio Data Encoding, and Domain-Independent Geometric Data Distribution
https://doi.org/10.5281/zenodo.19280784 The Universal Proportional Coordinate System: A Unified Architecture for Pythagorean Tuning, Exact-Ratio Data Encoding, and Domain-Independent Geometric Data Distribution